After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust.
Hawai’i Life appoints Palo Luckett principal broker and Alex Abreu as weekend broker, plus Adam Snyder to lead agent success and innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results